The American Journal of Managed Care®'s annual Patient-Centered Oncology Care® brings together
Dr Harlan Levine Previews Focus of Featured Discussion at Patient-Centered Oncology Care® 2020
September 14th 2020During a featured discussion at this year’s Patient-Centered Oncology Care® 2020 virtual meeting, innovations and subsequent challenges in employing these advances within the treatment of cancer will be addressed.
Read More
Dr Karen Winkfield on Chief PCOC 2020 Message, Importance of Diversity in the Oncology Workforce
September 11th 2020Understanding each patient's individual story is vital in the transition to patient-centered care. Additionally, matching patients with physicians of the same race and background can boost comfortability among patients.
Read More
Dr Kashyap Patel on Pressing Topics in Cancer Care Delivery to Be Discussed at PCOC 2020
September 8th 2020The top 3 issues relevant within cancer care delivery to be discussed at this year's virtual Patient-Centered Oncology Care Conference 2020 will include COVID-19, pharmacy benefit managers, and alternative payment models.
Read More
Dr Joseph Alvarnas Previews Key Discussions in Oncology to Be Presented at PCOC 2020
September 8th 2020Each Patient-Centered Oncology Care meeting provides dynamic, provoking conversations on the current and future landscape of oncology. This year's PCOC 2020 will work to continue this trend.
Read More
Dr Joshua Ofman: Improving Survival, Reducing Costs in Oncology Vital to Value-Based Care Transition
February 6th 2020From a value-based medicine perspective, we think there's no greater value in the healthcare system than improving survival for cancer patients and reducing the costs of treating late stage cancer; we believe the GRAIL test could be the test case for how to make this transition, said Joshua Ofman, MD, MSHS, chief of Corporate Strategy and External Affairs at GRAIL Inc.
Read More
Rani Khetarpal Highlights the Biggest Misconception Linked With Care Pathways
January 27th 2020Pathways are not trying to restrict or take control of treating the patient from the physician, it’s actually trying to enhance that for the physician and take the guesswork of how to do that out of it, said Rani Khetarpal, MBA, vice president of Oncology Value-Based Partnerships at New Century Health.
Read More
Jennifer Atkins Explains How Blue Cross Blue Shield Evaluates Emerging Innovations in Cancer Care
January 17th 2020Blue Cross Blue Shield utilizes data to drive insights into what works and what doesn't work in cancer care, as well as, delineating trends through our collaboration with provider specialties and organizations across the US, said Jennifer Atkins, MBA, vice president of Network Solutions at Blue Cross Blue Shield.
Read More
Dr Stephen Edge Discusses the Role of Patient Reported Outcomes and Quality Metrics in Oncology Care
January 5th 2020The patient's voice is important in analyzing and evaluating the effectiveness of care, as well as in assessing the value of new treatments, said Stephen Edge, MD, FACS, FASCO, vice president of Healthcare Outcomes and Policy at Roswell Park Cancer Institute.
Read More
Rani Khetarpal Discusses Approaches by New Century Health to Manage Risk and Cost of Care
January 5th 2020Through the risk-based, capitated model it has implemented, New Century Health promotes the ability to control drug costs without jeopardizing care for the patient, said Rani Khetarpal, MBA, vice president of Oncology Value-Based Partnerships at New Century Health.
Read More
Jennifer Atkins Describes Blue Cross Blue Shield's Commitment to Innovations in Oncology
December 8th 2019Blue Cross Blue Shield is dedicated to maintaining local relationships to ensure they can provide the best care continuum to patients, said Jennifer Atkins, MBA, vice president of Network Solutions at Blue Cross Blue Shield.
Read More
Dr Joshua Ofman: Early Detection of Cancer Is Vital to the Progression of Oncology Care
November 22nd 2019GRAIL has generated enormous innovations in oncology care over the past 2 decades and will continue this trend through exploring 1 of oncology’s biggest opportunities, early detection of cancer, said Joshua Ofman, MD, chief of Corporate Strategy and External Affairs at GRAIL Inc.
Read More
Rani Khetarpal Details Early Thoughts on the Oncology Care First Model
November 13th 2019While it is too early to provide insight into whether or not the OCF model will be successful, I think its preliminary ideas are a step in the right direction, said Rani Khetarpal, MBA, vice president of Oncology Value-Based Partnerships at New Century Health.
Read More
Money, Mandate Are Keys to FDA's Drive for Use of Real-World Evidence, Gottlieb Says
November 12th 2019Former FDA Commissioner Scott Gottlieb, MD, who has returned to the American Enterprise Institute, left FDA in April after 2 whirlwind years that saw a record pace of approvals and policy actions that covered everything from high drug prices to teen vaping. He spoke Friday in Philadelphia at Patient-Centered Oncology Care®, the annual meeting of oncology reimbursement stakeholders held by The American Journal of Managed Care®.
Read More
The Fast Pace of CAR T-Cell Innovation Caused an Array of Challenges in Treatment
November 10th 2019The evidence shows that chimeric antigen receptor (CAR) T-cell therapies are effective, but the price tags on these treatments are high and have raised concerns about how many patients will get treated. During a discussion at The American Journal of Managed Care®’s Patient-Centered Oncology Care® meeting, held Friday in Philadelphia, panelists outlined the efficacy of the 2 FDA-approved therapies, Medicare reimbursement for CAR T-cell therapies, and the pace of innovation in healthcare.
Read More
There are similarities between the challenges of accessing good cancer care in rural areas of the United States and Rwanda, such as poverty, transportation, and lack of routine care, said Lawrence N. Shulman, MD, director of the Center for Global Cancer Medicine at the Abramson Cancer Center, and professor of Medicine at the Hospital of the University of Pennsylvania.
Read More
Dr Brian Koffman Outlines the Follow-up as a Patient Treated With CAR T
November 24th 2018After being treated for his chronic lymphocytic leukemia with chimeric antigen receptor (CAR) T-cell therapy, Brian Koffman, MDCM, DCFP, DABFM, MS Ed, medical director, CLL Society, is being followed for 15 years to better understand if there are any undiscovered adverse events that pop up and how durable the response is.
Read More
Beth Wittmer on Educating Patients on Neutropenia as a Side of Effect of Cancer Treatment
November 22nd 2018As patients start chemotherapy to treat their cancer, they are educated on the side effects, particularly neutropenia, said Beth Wittmer, RN, OCN, manager of care management at Florida Cancer Specialists and Research Institute.
Read More
AMA's McAneny Calls for Real-time Oncology Payment Model Led by Physicians
November 17th 2018In the keynote address at Patient-Centered Oncology Care® 2018, Barbara McAneny, MD, a New Mexico oncologist/hematologist and the current president of the American Medical Association (AMA), shared her diagnosis for the current crisis in US healthcare, as well as a prescription—a new real-time oncology payment model led by physicians.
Read More
Dr Brian Koffman Highlights the Benefits and Risks of CAR T Therapy
November 17th 2018Since chimeric antigen receptor (CAR) T-cell therapy is still in early development there are benefits and risks that eligible patients will have to weigh, including the durable response against the limited amount of data and toxic side effects, said Brian Koffman, MDCM, DCFP, DABFM, MS Ed, medical director, CLL Society.
Read More
Keeping Ahead of the Curve in the Transition to Oncology Value-Based Payment
November 16th 2018At a session of The American Journal of Managed Care®'s Patient-Centered Oncology Care® 2018 meeting, held November 16 in Philadelphia, panelists shared their views on the future of oncology value-based payment models and how they as payers and providers can help advance these models.
Read More
Dr Marcus Neubauer Discusses the Evolution of Care Teams in Oncology
November 16th 2018As practices shift to value-based care, they need truly coordinated care teams that discuss high-risk patients and identify ways to deliver care to them, said Marcus Neubauer, MD, chief medical officer, US Oncology.
Read More
Dr Mark Fleury Highlights ACS CAN's Advocacy Efforts
June 11th 2018Mark Fleury, PhD, MS, principal of Policy Development and Emerging Science at the American Cancer Society Cancer Action Network (ACS CAN), has highlighted the advocacy efforts the organization was involved in from the local level to the federal level.
Read More
The latest version of FDA's patient-focused drug development initiative is trying to gather patient perspectives in a systematic way, but the effort faces the challenge of understanding the spectrum of those perspectives, said Mark Fleury, PhD, MS, principal of Policy Development and Emerging Science at the American Cancer Society Cancer Action Network (ACS CAN).
Read More
Ian Manners Outlines Pharma's Participation in Providing Financial Assistance for Patients
May 23rd 2018Only a small percent of patients eligible for assistance programs actually enroll, and Vivor is working with pharmaceutical companies to make the process of using patient assistance programs smoother, said Ian Manners, founder and CEO of Vivor.
Read More
Dr Mark Fleury on 21st Century Cures and Cancer Care
May 21st 2018The 21st Century Cures Act, in many ways, helps drugs in other disease areas going through review with FDA get to the same standard of the oncology area, said Mark Fleury, PhD, MS, principal of Policy Development and Emerging Science at the American Cancer Society Cancer Action Network (ACS CAN).
Read More
Dr Stacey McCullough Discusses Teamwork and Collaboration in Oncology
April 13th 2018Stacey McCullough, PharmD, senior vice president of pharmacy at Tennessee Oncology, discusses the importance of the pharmacist there are more advances being made and therapeutic options becoming available in oncology.
Read More